FDA Grants Emergency Use Authorization For Anthrax Vaccine

The ability to opt-out of the inoculation under the Anthrax Vaccine Immunization Program is one condition of FDA’s clearance of Anthrax Vaccine Adsorbed for the prevention of inhalation anthrax. The authorization is the first use of the Emergency Use Authorization under BioShield Act of 2004.